Biosimilars

Biosimilars are biopharmaceutical medicines that are structurally and functionally similar to an already existing, approved biological medicine (known as the reference product). They are made using a living organism and contain complex proteins that cannot be reproduced synthetically. Biosimilars have the potential to reduce healthcare costs while maintaining the same safety and efficacy as the original medicines. Additionally, biosimilars are a sustainable, cost-effective alternative to innovator drugs and provide increased access to medicines to a much larger population. In particular, biosimilars are increasingly being used to treat chronic diseases such as cancer, rheumatoid arthritis, and Crohn’s disease, as well as other conditions.